# ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-to-present-at-the-piper-sandler-37th-annual-healthcare-confe-af00c677
Ticker: ANIP
Company: ANI Pharmaceuticals
Source: ANI Pharmaceuticals
Published: 2025-11-25 11:50 EST
## Summary

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani,...

## Article Body
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37 th Annual Healthcare Conference on Tuesday, December 2, at 2:00 p.m. ET.

The live and archived fireside chat will be accessible from the Company’s website at www.anipharmaceuticals.com , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com .

Investor Relations: Courtney Mogerley, Argot Partners T: 646-368-8014 E: ani@argotpartners.com
## Recent Company News
- 2026-07-24 10:50 EST — [ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-to-discuss-second-quarter-2026-financial-results-on-august-7-f8a7cc57) — Source: ANI Pharmaceuticals
- 2026-07-16 20:34 EST — [ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-announces-intent-to-appeal-rulings-in-cg-oncology-matter-62a30dad) — Source: ANI Pharmaceuticals
- 2026-07-13 10:50 EST — [ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-announces-positive-six-month-topline-data-from-the-phase-4-o-658a24f6) — Source: ANI Pharmaceuticals
- 2026-05-27 10:50 EST — [ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conferenc-f9d25fa3) — Source: ANI Pharmaceuticals
- 2026-05-08 10:50 EST — [ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-reports-first-quarter-2026-financial-results-and-raises-2026-8805534e) — Source: ANI Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)